These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34133018)

  • 1. Critical interactions between opioid and cannabinoid receptors during tolerance and physical dependence development to opioids in the murine gastrointestinal tract: proof of concept.
    Szymaszkiewicz A; Świerczyński M; Talar M; Polepally PR; Zjawiony JK; Fichna J; Zielińska M
    Pharmacol Rep; 2021 Aug; 73(4):1147-1154. PubMed ID: 34133018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the cannabinoid CB1 receptor in the opioid inhibition of the response to cholecystokinin and acute withdrawal response.
    Romanelli L; Palmery M; Tucci P; Amico MC; Morrone LA; Valeri P
    Neurotoxicology; 2005 Oct; 26(5):819-27. PubMed ID: 15913779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
    Ramesh D; Ross GR; Schlosburg JE; Owens RA; Abdullah RA; Kinsey SG; Long JZ; Nomura DK; Sim-Selley LJ; Cravatt BF; Akbarali HI; Lichtman AH
    J Pharmacol Exp Ther; 2011 Oct; 339(1):173-85. PubMed ID: 21719468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction.
    Mas-Nieto M; Pommier B; Tzavara ET; Caneparo A; Da Nascimento S; Le Fur G; Roques BP; Noble F
    Br J Pharmacol; 2001 Apr; 132(8):1809-16. PubMed ID: 11309253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
    Trang T; Sutak M; Jhamandas K
    Neuroscience; 2007 May; 146(3):1275-88. PubMed ID: 17395382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of tolerance in the guinea pig ileum produced by chronic in vivo exposure to opioid versus cannabinoid agonists.
    Maguma H; Thayne K; Taylor DA
    Biochem Pharmacol; 2010 Aug; 80(4):522-32. PubMed ID: 20478271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-tolerance and convergent dependence between morphine and cannabimimetic agent WIN 55,212-2 in the guinea-pig ileum myenteric plexus.
    Basilico L; Parolaro D; Colleoni M; Costa B; Giagnoni G
    Eur J Pharmacol; 1999 Jul; 376(3):265-71. PubMed ID: 10448886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence.
    Trang T; Ma W; Chabot JG; Quirion R; Jhamandas K
    Pain; 2006 Dec; 126(1-3):256-71. PubMed ID: 16935424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
    Capasso A; Gallo C
    Curr Drug Saf; 2009 May; 4(2):97-102. PubMed ID: 19442100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.
    Pacheco Dda F; Klein A; Perez AC; Pacheco CM; de Francischi JN; Reis GM; Duarte ID
    Br J Pharmacol; 2009 Sep; 158(1):225-31. PubMed ID: 19594755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid CB
    Iyer V; Slivicki RA; Thomaz AC; Crystal JD; Mackie K; Hohmann AG
    Eur J Pharmacol; 2020 Nov; 886():173544. PubMed ID: 32896549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids and the gastrointestinal tract.
    Pertwee RG
    Gut; 2001 Jun; 48(6):859-67. PubMed ID: 11358910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by immunophilin ligands of morphine-induced tolerance and dependence in guinea pig ileum.
    Mehr SE; Samini M; Namiranian K; Homayoun H; Gaskari SA; Dehpour AR
    Eur J Pharmacol; 2003 Apr; 467(1-3):205-10. PubMed ID: 12706476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine.
    Mundey MK; Mason R; Wilson VG
    Br J Pharmacol; 1998 Jul; 124(5):911-6. PubMed ID: 9692776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.